01.01.20265 min read

AI-Powered Laboratory Automation: The Next Step in Research Efficiency

Explore AI laboratory automation, improve research efficiency, ensure data integrity, and streamline workflows for faster, compliant lab operations.

When regulated laboratories across Eurasia assess AI in laboratory automation, the first question is rarely curiosity. The risks are data integrity, traceability, and audit readiness. Analitika Expo 2026 brings that procurement reality together in one place, with 230+ exhibitors from 20+ countries. For suppliers of laboratory equipment and chemical reagents, the exhibition is a marketplace where specifications meet validation plans, budgets, and purchase approvals.
 

Procurement Priorities

 

Senior laboratory buyers purchase outcomes, then manage the consequences. They protect product quality, patient safety, and business continuity. Each instrument, reagent, and service is assessed against regulatory frameworks and internal controls, as well as the total cost of ownership and service risk.

Standards alignment
 

In regulated environments, purchasing decisions are governed by established quality and compliance frameworks that shape both evaluation and approval processes:

  • ISO standards define baseline expectations for quality systems, calibration, laboratory competence, and documentation control.
  • Organisation for Economic Co-operation and Development (OECD) principles set requirements for Good Laboratory Practice (GLP), particularly within testing, toxicology, and safety assessment laboratories.

     
  • United States Food and Drug Administration (FDA) guidance sets expectations for validation, data integrity, and system control for laboratories supporting pharmaceutical and life sciences operations.

     
  • European Medicines Agency (EMA) requirements shape compliance expectations across clinical, analytical, and manufacturing-linked laboratory environments in regulated markets.

     
  • International Council for Harmonisation (ICH) guidance provides a common reference point for analytical validation, quality risk management, and lifecycle control where applicable.
     

Lifecycle value
 

Laboratory procurement is evaluated long after the purchase order is placed. Buyers look for preventive maintenance, spares availability, and service response times. They also assess reagent continuity, lot-to-lot consistency, and storage requirements. Software support terms matter, especially when analytical instrumentation relies on controlled updates and secure configurations. In parts of the CIS and Eastern Europe, import complexity and lead times can affect continuity planning, making local service capability a key factor in decision-making.
 

Technical Evaluation
 

Strong datasheets are table stakes. Regulated buyers still need to validate performance in their own context, with their sample matrices, throughput targets, and staffing realities.


Evidence beyond specifications
 

Face-to-face technical evaluation reveals constraints that are hard to capture online. Buyers probe pipetting accuracy at low volumes, carryover control, contamination mitigation, and environmental tolerances. They question method transfer, system suitability, and traceable calibration. They also ask how systems behave under routine load, with staff rotation and planned downtime.

For suppliers of advanced lab instruments, credibility is earned through detailed demonstration: exception handling, audit trail behaviour, and how deviations are recorded and escalated.
 

Data integrity and validation


Automation and software have become core purchase criteria. Buyers look for role-based access control, time-stamped audit trails, and clear electronic record governance. They ask how updates are tested, how configurations are locked, and how data are backed up and recovered. When laboratories operate under Good Manufacturing Practice, the discussion covers computer system validation and data integrity expectations, including records that are attributable, legible, contemporaneous, original, and accurate.
 

Decision Access
 

Exhibiting works when the buyer mix matches the supplier’s deal profile. Analitika Expo is designed around decision-makers who influence purchasing across operations, quality, compliance, and research.

 

Cross-functional approval routes
 

In regulated laboratories, a purchase seldom falls within a single function. Laboratory managers define workflows and capacity. Quality assurance teams assess compliance impact. R&D directors assess scientific fit. Procurement managers manage commercial terms, supplier approval, and tender rules. This reality favours suppliers who can maintain a consistent, evidence-based conversation with stakeholders, backed by documentation aligned with regulated workflows and quality systems.
 

Regional procurement dynamics


Across Eurasia, buyers often work within annual budget cycles and centralised purchasing. Many also operate through distributor models or are constrained by currency, logistics, and lead times. Exhibitors who understand these dynamics can reduce risk early by defining delivery terms, securing commissioning support, and selecting service models that reduce downtime. That matters commercially because delayed qualification can cost more than the equipment itself due to lost capacity and rework.

For suppliers with automated laboratory research solutions, this is also where qualification planning, training scope, and integration timelines can be agreed upon before formal tendering begins.
 

Exhibitor Readiness
 

Suppliers should treat Analitika Expo as a procurement platform and prepare accordingly. The aim is to reduce buyer uncertainty by providing evidence that extends beyond the stand.
 

Documentation and proof
 

High-performing teams deliver a concise validation pack: performance data with traceable references, service-level options, and documented software governance. They prepare answers on installation qualification, operational qualification, and performance qualification expectations, even when those activities will be executed with the customer. They also provide clear statements on consumables, calibration, and contamination control, as these factors shape ongoing risk.

 

Commercial discipline

 

Exhibitors gain more by qualifying conversations than by collecting contacts. We use a simple triage: confirm the regulatory context, the intended use and throughput, and the decision timeline and approval route. That keeps discussions focused on decision readiness and reduces unproductive follow-up.
 

Position Your Solutions in Active Procurement Cycles

 

If your organisation supplies laboratory equipment, analytical instrumentation, or chemical reagents into regulated environments, exhibiting at Analitika Expo is a direct route to qualified procurement conversations. The exhibition places your technical specialists directly in front of decision-makers assessing risk, compliance readiness, and lifecycle value ahead of tender issuance.

Submit an exhibit enquiry for Analitika Expo 2026 today!

Analitika Expo